OK,,,,PLSIA WAS HOT LOOK FOR MORE ACTION UP ON MONDAY
looking for 21
also symp play is blti,,,another laser co in line up for fda,will move up with plsia monday,,,,,news will hit all over the world for sure this weekend,,,,,much talks about it now on bb s
strong buy 330pm est,,,most prob did not see it ,,,went home
PLSIA looks like one of the situations where there will be a multi-day run. We saw a similar phenomeno with CFON, ENML and QGLY.
<< NEW YORK--(BW HealthWire)--May 9, 1997--Senior Analyst, Scott
Baily at BlueStone Capital reiterates his investment rating on
Premier Laser Systems, Inc. (NASDAQ: PLSIA) of a STRONG BUY
recommendation.
-- On May 7, 1997, PLSIA announced that the company received FDA
approval of its Centauri Erbium: YAG laser for hard-tissue
procedures. The FDA clearance to market its Centauri laser is the
first-ever granted in the U.S., and effectively gives PLSIA, in our
opinion, a 1 1/2 to 3 year lead over the competition.
-- Following PLSIA's FDA approval of the Centauri this week, we
are reiterating our STRONG BUY recommendation for long-term
investors. In our view, the long-term outlook for the company
continues to get better. However, given the nearly doubling of
PLSIA's stock price -- up 95% -- since our most recent
recommendation at $5 5/8, we would not be surprised to see some
short-term profit taking.
-- With institutional investors currently holding less than 1%
of PLSIA's common stock outstanding, we believe considerable
institutional demand is likely in the months ahead. Additionally,
since we are the only research coverage on Wall Street, as more
analysts begin to follow the company, we would anticipate that the
added sponsorship would also favorably impact the stock.
BlueStone Capital Partners, L.P. is a full service investment
banking and brokerage firm that delivers financial services to
emerging growth and medium size companies worldwide. BlueStone
Capital assists clients in maximizing their growth by providing
sophisticated investment strategies that are designed to achieve
clients' strategic, operating and financial goals.
--30--rc/ny* al |
